Storage and handling
Store between 15°C - 30°C (59°F - 86°F).
Store between 15°C - 30°C (59°F - 86°F).
Dextrose • H2O.................................... 75.0 g
Calcium .............................................. 10.8 g
(as calcium borogluconate)
Potassium ........................................... 8.0 g
(as potassium chloride)
Phosphorus .......................................... 2.5 g
(as sodium hypophosphite • H2O)
Magnesium ........................................... 1.6 g
(as magnesium borogluconate)
For use in cattle as an aid in treatment of conditions associated with calcium,
magnesium, phosphorus, potassium or glucose deficiencies.
DO NOT administer this product to animals showing signs of cardiac distress. Monitor animal's condition closely.
Entire contents should be used when first entered as this product contains no preservatives. Do not use if solution is not clear.
Discard any unused portion.
Cattle ...............500 mL/800-1000 lbs body weight.
For intravenous administration only. Solution should be warmed to body temperature and administered slowly using aseptic precautions.
Store between 15°C - 30°C (59°F - 86°F).
TAKE TIME OBSERVE LABEL DIRECTIONS
Keep Out of Reach of Children
For Animal Use Only
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Manufactured by:
Nova-Tech, Inc.
Grand Island, NE 68801 USA
18-805
RMS 92-336
NDC: 65207-805-50
Nova-Tech® Animal Health
Calcium-Magnesium-Phosphorus-Potassium-Dextrose
Steril Solution
Net Contents:
500 mL (16.91 fl oz)
Assembled in USA
Lot No.
Exp. Date
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0065207805506 | GTIN-13: 0065207805506 EAN-13: 0065207805506 GTIN-12: 065207805506 UPC-A: 065207805506 GTIN storage (14 digits): 00065207805506 | 92-336.jpg |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 65207-805 | 65207-805-50 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Dextrose monohydrate | LX22YL083G | ACTIB |
| Potassium Chloride | 660YQ98I10 | ACTIM |
| Calcium Gluconate Monohydrate | CZN0MI5R31 | ACTIB |
| Phosphorus | 27YLU75U4W | ACTIB |
| Magnesium Gluconate | T42NAD2KHC | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2020-03-18 | full-release | 2026-06-01 02:40:44 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | BECTON DICKINSON AND COMPANY | 32132016-1870-481b-9816-e11beb03ca0b | 2026-01-08 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | bd250a46-d229-4e80-b5a1-b34169ccecc4 | 2025-12-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | cb578dba-094c-4787-951d-763d12fd06e1 | 2025-11-01 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical Inc. | cdf35d11-fbc8-4f8e-85a8-33220312c0b4 | 2025-10-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | bfc4224a-2fc9-4137-b4c6-9d2d6d948413 | 2025-07-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3842a9c0-8b15-1c94-e063-6394a90ae120 | 2025-07-18 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 36e9478c-5df0-4b47-b97d-de3626d7cb29 | 2025-06-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
Adverse event summaries are temporarily unavailable. Other product information remains available.